SPHERA FUNDS MANAGEMENT LTD.

Position in SVRA — Savara Inc

CIK 1496201 TEL AVIV, L3

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,035,835

-$3,068,493 QoQ

Shares Held

739,164

-37.3% QoQ

Ownership

0.361%

of shares outstanding

% of Portfolio

0.70%

of 13F equity value

Holder Rank

#39

of 184 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $325,221,568 across 61 Biotechnology names. SVRA ranks #32 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	1,339,971	$36,299,814
2	BBIO	BridgeBio Pharma, Inc.	245,246	$18,211,967
3	RARE	Ultragenyx Pharmaceutical Inc.	809,333	$16,955,526
4	SNDX	Syndax Pharmaceuticals Inc	724,563	$16,925,791
5	COGT	Cogent Biosciences, Inc.	416,340	$16,024,926
6	FOLD	AMICUS THERAPEUTICS, INC.	603,377	$8,724,831
7	APLS	Apellis Pharmaceuticals, Inc.	214,914	$8,645,990
8	BMRN	Biomarin Pharmaceutical Inc	139,900	$7,902,951

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,035,835	739,164	-37.3%	Shares	Defined	2026-05-15
2025-12-31	$7,104,328	1,178,164	-12.8%	Shares	Defined	2026-02-17
2025-09-30	$4,820,688	1,350,333	+3.1%	Shares	Defined	2025-11-14
2025-06-30	$2,987,331	1,310,233	+2.0%	Shares	Defined	2025-08-14
2025-03-31	$3,557,098	1,284,151	+6.0%	Shares	Defined	2025-05-15
2024-12-31	$3,719,406	1,211,533	+115.2%	Shares	Defined	2025-02-14
2024-09-30	$2,387,573	563,107	-41.5%	Shares	Defined	2024-11-14
2024-06-30	$3,879,628	962,687	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.